Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
CIRCULATION Editor's Picks | Feb/March 2020
03/19/2020 | CIRCULATON Editor's Picks for January 2020
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
JAHA Conference Reads| EPI Lifestyle 2020
03/02/2020 | JAHA Conference Reads for EPI Lifestyle 2020
Exercise-Related Acute Cardiovascular Events & Potential Deleterious Adaptations
02/26/2020 | The benefits of regular moderate-to-vigorous physical activity (PA), and the associated improvements in cardiorespiratory fitness (CRF), far outweigh the risks for most individuals.
STROKE | Progress and Innovation Award 2019
02/12/2020 | Stroke 2019 Innovation and Progress Award Winners--first: Ma and Wang, Second: Yip, Third: Schlunk
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
CIRCULATION Editor's Picks | January 2020
01/28/2020 | CIRCULATON Editor's Picks for January 2020
HYPERTENSION | Editor's Picks | January 2020
01/24/2020 | Hypertension Trending Topics for January 2020